|
|
Article: HairDX Launches European Subsidiary To Expand Global Availability Of Genetic Baldness Test For Men And Women.
- Article from:
- Business Wire
- Article date:
- June 9, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IRVINE, Calif. AND HASSELT, Belgium -- Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC, pioneers of genetic tests for predicting the risk of male and female hair loss, today announced the launch of its European subsidiary, HairDX Europe.
HairDX Europe expands the company's leadership in hair dermatology, and global availability of the genetic tests for Androgenetic Alopecia. This follows the recent announcement of distribution agreements with Biodue in Italy, and Aderans in Japan. HairDX's revolutionary genetic tests in Italy, and further expands the company's leadership in the dermatology of hair.
...